Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JTS2400110	注射用培重组人凝血因子VIII	Lyophilized	Biological Products	Disposable Import Drug Application	2024-09-25					view
JTS2400109	注射用培重组人凝血因子VIII	Lyophilized	Biological Products	Disposable Import Drug Application	2024-09-25					view
JTS2400108	注射用培重组人凝血因子VIII	Lyophilized	Biological Products	Disposable Import Drug Application	2024-09-25					view
JTS2400107	注射用培重组人凝血因子VIII	Lyophilized	Biological Products	Disposable Import Drug Application	2024-09-25					view
JTS2400106	注射用培重组人凝血因子VIII	Lyophilized	Biological Products	Disposable Import Drug Application	2024-09-25					view
JTS2400105	注射用培重组人凝血因子VIII	Lyophilized	Biological Products	Disposable Import Drug Application	2024-09-25					view
JTS2400104	注射用培重组人凝血因子VIII	Lyophilized	Biological Products	Disposable Import Drug Application	2024-09-25					view
CXSL2000373	注射用培重组人凝血因子VIII-Fc融合蛋白	Lyophilized	Biological Products(1)	New Drug Application	2020-12-23	海门晟斯生物制药有限公司	Jiangsu Shengsi Biopharmaceutical Co Ltd	In Review	2020-12-22	view
CXSL2000372	注射用培重组人凝血因子VIII-Fc融合蛋白	Lyophilized	Biological Products(1)	New Drug Application	2020-12-23	海门晟斯生物制药有限公司	Jiangsu Shengsi Biopharmaceutical Co Ltd	In Review	2020-12-22	view
CXSB2300106	注射用培重组人凝血因子VIII-Fc融合蛋白	Lyophilized	Biological Products(1)	Supplementary Application	2023-10-11		Jiangsu Shengsi Biopharmaceutical Co Ltd			view
CXSB2300105	注射用培重组人凝血因子VIII-Fc融合蛋白	Lyophilized	Biological Products(1)	Supplementary Application	2023-10-11		Jiangsu Shengsi Biopharmaceutical Co Ltd			view